Possible Association Between Migraine and Meniere’s Disease
Meniere’s disease is classified as a vestibulocochlear disorder characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and a feeling of ear pressure. Recent years have seen a growing scientific interest in the connection between migraine and Meniere’s disease. Previous studies indicate that migraine patients often exhibit symptoms typical of Meniere’s disease at a disproportionately high rate.
Study Examining the Incidence of Meniere’s Disease in Migraine Patients and the Possible Influence of Migraine Therapies
In this context, a recent retrospective study investigated the relationship between migraine, migraine therapy, and the occurrence of Meniere-associated symptoms. The aim was to compare the incidence of Meniere’s disease and Meniere-associated symptoms among different patient groups, including migraine patients, non-migraine patients, and both treated and untreated migraine patients.
The research utilized data from approximately 61,000 individuals from the TriNetX database between 2013 and 2025. Propensity score matching was applied to adjust for potential confounding factors such as age, gender, ethnicity, and known risk factors for Meniere’s disease. Both the incidence of manifest Meniere’s disease and typical symptoms, such as tinnitus, hearing loss, vertigo, and ear pressure, were examined over periods extending up to five years.
Migraine Patients Showed Increased Incidence of Meniere’s Disease
The study’s authors demonstrated that migraine patients exhibited a higher incidence of Meniere’s disease and Meniere-associated symptoms (ear pressure, tinnitus, hearing loss, and vertigo) compared to individuals without migraine. These findings support the hypothesis of a shared pathophysiological basis between both conditions.
Increased Meniere Incidence in Treated Migraine Patients
It was previously unknown that migraine patients receiving therapy showed greater predisposition to develop Meniere’s disease or related symptoms compared to those not receiving medication. The authors note that these findings do not necessarily indicate a causal relationship between medication and disease onset. It is conceivable that these patients have more severe migraine symptoms requiring treatment. Studies have shown that more severe migraines correlate with elevated levels of vasoactive CGRP (Calcitonin Gene-Related Peptide), which could lead to increased trigeminal inflammation, making patients more susceptible to Meniere-associated symptoms.
However, no significant differences were observed regarding the incidence of hearing loss or ear pressure between treated and untreated migraine patients. The researchers explained this outcome by the effectiveness of migraine therapies in alleviating vestibulocochlear symptoms as well.
Untreated Migraine Patients More Frequently Experienced Tinnitus
Untreated migraine patients, on the other hand, had an increased risk of developing tinnitus, a finding already noted in the literature. Relevant studies suggest that medications used in migraine therapy may improve Tinnitus Functional Index Scores.
Could Migraine Medications Also Help Meniere’s Disease?
This study could offer clinical implications, suggesting that in migraine patients suffering from vertigo, tinnitus, or hearing loss, Meniere’s disease should also be considered. The scientists also pointed out that migraine therapies might potentially benefit Meniere’s disease patients. They may even prevent or slow down the progression of Meniere’s disease in migraine patients, thereby improving the quality of life for those affected.
